Skip to content

Public FDA record

Z-1012-2018: The GLOBAL UNITE Platform Shoulder System is intended for cemented or uncemented total shoulder or hemi-s

Recall record Z-1012-2018 for DePuy Orthopaedics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1012-2018
Company in FDA record
DePuy Orthopaedics, Inc.
FDA classification date
Feb 27, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The screw in specific lots of the GLOBAL UNITE Anatomic Body and GLOBAL UNITE Fracture Body was inverted during assembly to the body, which will cause the humeral stem to sit proud and may cause surgical delays.

Source facts

Action
DePuy Orthopaedics, Inc. is voluntarily recalling 11 lots of the GLOBAL UNITE Platform Shoulder System. The device is being recalled because the screw in specific lots of the GLOBAL UNITE Anatomic Body and GLOBAL UNITE Fracture Body was inverted during assembly to the body, which will cause the humeral stem to sit proud and may cause surgical delays. Once the screw is properly assembled, there is no additional risk to the patient. Further distribution or use of the affected lots is to cease immediately.DePuy Orthopaedics, Inc. is not recommending prophylactic revision. The company recommends that surgeons discuss potential clinical implications and risks with symptomatic patients that received the affected lots and may have experienced a surgical delay. Please take the following actions: Please cease using the affected components immediately. Return affected devices: Medical facilities are to determine if any of the recalled devices are still on hand, and return affected devices immediately to their DePuy Synthes Sales Consultant or return them to DePuy Synthes Joint Reconstruction for credit following normal procedures. Reconciliation forms should be faxed to 574-371-4939. Note: The affected lots may be on consignment at your facility. Reconciliation Form: Complete the Reconciliation Form and return to your DePuy Synthes Sales Consultant, email to DPYUS-JointReconFieldActions@its.jnj.com, or fax to 574-371-4939 within five (5) days of this notice. Records: Retain a copy of the completed Reconciliation Form in your files along with this notice. Additional Notifications: Notify surgeons at your facility by providing them with a copy of this notice to ensure surgeons are aware of this recall. Forward this notice to others in your facility that need to be informed.If any affected product has been forwarded to another facility, contact that facility immediately to communicate this field action with the facility/facilities. Maintain a copy of this notice wi
Initiated
2017-11-28
Root cause
Employee error
Terminated
2020-03-27
Distribution
Distribution Level: The device removal is extended to the companies US Distributors/Sales Offices and Medical Facilities that may have used, purchased, or received the affected devices. Approximately 53 units distributed to firm's international affiliates.
Recall number
Z-1012-2018
Recall status
Terminated
CDRH record ID
161767
FDA classified
2018-02-27
Recall event number
79257

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗